Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Net Income (2016 - 2025)

Anaptysbio's Net Income history spans 10 years, with the latest figure at $62.7 million for Q4 2025.

  • For Q4 2025, Net Income rose 387.74% year-over-year to $62.7 million; the TTM value through Dec 2025 reached -$164000.0, up 99.89%, while the annual FY2025 figure was -$164000.0, 99.89% up from the prior year.
  • Net Income reached $62.7 million in Q4 2025 per ANAB's latest filing, up from $15.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $62.7 million in Q4 2025 to a low of -$46.7 million in Q2 2024.
  • Average Net Income over 5 years is -$23.4 million, with a median of -$31.2 million recorded in 2021.
  • Peak YoY movement for Net Income: crashed 6121.91% in 2022, then surged 387.74% in 2025.
  • A 5-year view of Net Income shows it stood at -$31.1 million in 2021, then rose by 28.8% to -$22.1 million in 2022, then crashed by 90.51% to -$42.2 million in 2023, then soared by 48.34% to -$21.8 million in 2024, then soared by 387.74% to $62.7 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Net Income are $62.7 million (Q4 2025), $15.1 million (Q3 2025), and -$38.6 million (Q2 2025).